PRESS RELEASE published on 03/24/2023 at 07:30, 1 year 7 months ago Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
PRESS RELEASE published on 03/21/2023 at 11:50, 1 year 8 months ago Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023
PRESS RELEASE published on 03/16/2023 at 07:30, 1 year 8 months ago Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb
PRESS RELEASE published on 02/10/2023 at 07:30, 1 year 9 months ago Evotec receives € 150 m loan from European Investment Bank
PRESS RELEASE published on 02/09/2023 at 07:30, 1 year 9 months ago Evotec and Related Sciences expand integrated drug discovery and development partnership
PRESS RELEASE published on 02/07/2023 at 07:30, 1 year 9 months ago Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
PRESS RELEASE published on 01/26/2023 at 07:30, 1 year 9 months ago Evotec announces agreement with Janssen to develop immune-based therapies
Published on 11/22/2024 at 23:55, 9 hours 22 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 47 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 12 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 47 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 23 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 21 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 17 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
